Skip to content
← Full study record

NCT01026220 · OUTCOME

Grade 3 and 4 Non-hematologic Toxicities During Protocol Therapy

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
During and after completion of study treatment.

What was measured

The number of patients that experience Common Terminology Criteria (CTC) Version 4 grade 3 or higher non-hematologic toxicity at any time during protocol therapy.

Analysis population: 165 eligible patients.

Groups in this outcome

Group 1

All Patients

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Group 1165

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Group 172Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        72
denoms
  1. counts
    1. group Id
      OG000
      value
      165
    units
    Participants
description
The number of patients that experience Common Terminology Criteria (CTC) Version 4 grade 3 or higher non-hematologic toxicity at any time during protocol therapy.
groups
  1. description
    All Patients
    id
    OG000
    title
    Group 1
param Type
NUMBER
population Description
165 eligible patients.
reporting Status
POSTED
time Frame
During and after completion of study treatment.
title
Grade 3 and 4 Non-hematologic Toxicities During Protocol Therapy
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice